This Framework Agreement is for the supply of Lenalidomide to health boards across NHS Scotland. Full details are contained in section II.2 of this notice.
- Procurement
- NP39722f Lenalidomide
- Buyer
- The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
- Published
- 21 Sept 2022
- Status
- complete
- CPV
- 33600000 — Pharmaceutical products
- Tender period
- —
Awards
- Accord-UK Ltdactive—
- Bristol-Myers Squibb Pharmaceuticalsactive—
- Glenmark Pharmaceuticals Europe Ltdactive—
- Morningside Pharmaceuticals Limitedactive—
- Piramal CCactive—
- Ranbaxy (UK) Ltdactive—
- Sandoz Ltdactive—
- Stragen UK Ltdactive—
- Teva UK Limitedactive—
- Thornton & Rossactive—
- Wockhardt UK Limitedactive—
- Mylanactive—
- Zentiva Pharma UK Ltdactive—
Other notices in this procurement
This is the only notice on record.
FAQs about this notice
What type of notice is this?
This is a award,contract published via Find a Tender on 21 Sept 2022.
Which procurement does this notice belong to?
It is part of "NP39722f Lenalidomide", published by The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority").
Has this notice resulted in an award?
13 awards are recorded on this notice, including to Accord-UK Ltd.
Get the full procurement picture
Enable turns the UK's public-contract data into pipeline intelligence for bid and capture teams. Talk to us about access, alerts and tailored market analysis.
Get in touch with Enable